Company / Inventory
Ligand Pharmaceuticals, Inc. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$9.1M
FY2025
5-year range
$9.1M / $27.3M
FY2021-FY2025
Trend
-35.3%
vs FY2024
Sector context
#90 of 105
Health Care
What the data says
Ligand Pharmaceuticals, Inc.'s inventory of $9M is lower than 86% of companies in the Health Care sector (FY2025). Inventory has fluctuated over the past 10 years, ranging from $2M in FY2016 to $27M in FY2021.
Based on SEC 10-K filings.
$9M in FY2025 with a 5-year CAGR of -19.2%.
Declined from $24M to $9M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -11.8%
- 5-Year CAGR
- -19.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 105This company $9.1M Sector average $885.3M
▼
-99.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -19.2%, indicating a declining trend.
- In FY2025, inventory decreased 35.3% year-over-year.
- Ranks #90 out of 105 companies in the Health Care sector.
- Peak inventory was recorded in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.1M | -35.3% |
| FY2024 | $14.1M | -41.1% |
| FY2023 | $24.0M | +80.3% |
| FY2022 | $13.3M | -51.4% |
| FY2021 | $27.3M | +3.2% |
| FY2020 | $26.5M | +263.0% |
| FY2019 | $7.3M | +2.4% |
| FY2018 | $7.1M | +62.9% |
| FY2017 | $4.4M | +127.4% |
| FY2016 | $1.9M | +17.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026